GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (LTS:0NIR) » Definitions » Asset Impairment Charge

Sartorius AG (LTS:0NIR) Asset Impairment Charge : €0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Sartorius AG Asset Impairment Charge?

Sartorius AG's Asset Impairment Charge for the three months ended in Sep. 2024 was €0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was €0 Mil.

Sartorius AG Asset Impairment Charge Historical Data

The historical data trend for Sartorius AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Asset Impairment Charge Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sartorius AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sartorius AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Sartorius AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (LTS:0NIR) » Definitions » Asset Impairment Charge
Comparable Companies
LSE:CTEC LSE:AMS LSE:TSTL LSE:BVC LSE:SPEC LSE:CNSL ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO XSWX:STMN HOLX TSE:7733 XPAR:DIM
Traded in Other Exchanges
SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT:Italy 1SRT3:Italy SRT3d:UK 0NIQ:UK SRT3:Germany SRT3:Bulgaria
Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Website
https://www.sartorius.com
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG Headlines

No Headlines